• 2594 Citations
  • 25 h-Index
1985 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ugo Nocentini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Multiple Sclerosis Medicine & Life Sciences
Chronic Progressive Multiple Sclerosis Medicine & Life Sciences
Brain Medicine & Life Sciences
Aptitude Medicine & Life Sciences
Cognition Medicine & Life Sciences
Frontal Lobe Medicine & Life Sciences
Semantics Medicine & Life Sciences
Parkinson Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2019

  • 2594 Citations
  • 25 h-Index
  • 70 Article
  • 10 Chapter
  • 1 Book
  • 1 Conference contribution

Assessing measurement invariance of MSQOL-54 across Italian and English versions

Giordano, A., Testa, S., Bassi, M., Cilia, S., Bertolotto, A., Quartuccio, M. E., Pietrolongo, E., Falautano, M., Grobberio, M., Niccolai, C., Allegri, B., Viterbo, R. G., Confalonieri, P., Giovannetti, A. M., Cocco, E., Grasso, M. G., Lugaresi, A., Ferriani, E., Nocentini, U., Zaffaroni, M. & 4 others, De Livera, A., Jelinek, G., Solari, A. & Rosato, R., Jan 1 2019, (Accepted/In press) In : Quality of Life Research.

Research output: Contribution to journalArticle

Multiple Sclerosis
Quality of Life
North America

Can personality traits influence occupational stress in multiple sclerosis patients? A one-year longitudinal study

Incerti, C. C., Argento, O., Magistrale, G., Di Battista, G., Ferraro, E., Caltagirone, C., Pisani, V. & Nocentini, U., Jan 1 2019, In : Applied Neuropsychology:Adult.

Research output: Contribution to journalArticle

Multiple Sclerosis
Longitudinal Studies
7 Citations (Scopus)

Disruption of neurite morphology parallels MS progression

Spano, B., Giulietti, G., Pisani, V., Morreale, M., Tuzzi, E., Nocentini, U., Francia, A., Caltagirone, C., Bozzali, M. & Cercignani, M., Nov 1 2018, In : Neurology: Neuroimmunology and NeuroInflammation. 5, 6, e502.

Research output: Contribution to journalArticle

Open Access
Diffusion Tensor Imaging
Diffusion Magnetic Resonance Imaging
38 Citations (Scopus)
Chronic Progressive Multiple Sclerosis
Disease Progression
Odds Ratio
102 Citations (Scopus)

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

EXPAND Clinical Investigators, Mar 31 2018, In : The Lancet. 391, 10127, p. 1263-1273 11 p.

Research output: Contribution to journalArticle

Chronic Progressive Multiple Sclerosis
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid